Tobacco Industry Behavior in the New FDA Era

Ballin, Scott

Thursday, August 16, 2012: 3:30 PM

2502 AB (Kansas City Convention Center)

Scott Ballin, JD , Health Policy Consultant, Washington, DC

Dr. Stanton Glantz, PhD , Center for Tobacco Control Research and Education, University of California San Francisco, San Francisco, CA

Dave Sweanor, JD , Faculty of Law, University of Ottawa, Ottowa, ON, Canada

Dr. Marty Otanez, PhD , Department of Anthropology, University of Colorado - Denver, Denver, CO

Learning Objectives

At the conclusion of this presentation attendees will be able to:

Describe
Explain
Outline

Cross Cutting Program Area(s): Tobacco Regulation and Communications and Media

Audience: All attendees

Key Points: Tobacco regulation is a new concept to many attendees

Educational Experience: The goal of this session will be to educate the audience about the behavior of the industry in the post-FDA era. The key question that will be posed to speakers is whether and how the tobacco industry has changed in the post-FDA period. Key question will be whether the industry has changed and if so, how.

Benefits: Attendees will be able to participate in a discussion with panelists.